Ann Melvin, MD, MPH
Associate Professor of Pediatric Infectious Diseases
Email: click here
Phone: (206) 987-2535
Dr. Melvin is co-director of the Pediatric HIV program at SCH. Her research interests are in the antiretroviral management of HIV disease in children and prevention and management of complications of HIV treatment. Dr. Melvin is co-principle investigator of the International Maternal Pediatric Adolescent Clinical Trials unit at the University of Washington, sponsored by the NIH, through which she is also chair or co-chair of several national and international research trials. She is also the co-director of the Regulatory Support and Bioethics Core of the Institute for Translational Health Sciences of the University of Washington. She collaborates with Drs. Englund, Frenkel, Corey, and Zerr.
Kansas State University, B.S., 1980
Oxford University, England, B.A., 1982
Tulane University School of Medicine, 1986
Tulane University School of Public Health and Tropical Medicine, M.P.H., 1986
University of California, San Francisco, Intern, 1986-87
Children's Hospital and Regional Medical Center/University of Washington, 1987-89
Children's Hospital and Regional Medical Center/University of Washington, 1989-92
Melvin, A. J., P. F. Lewis, K. M. Mohan, W. S. Naugler, and L. M. Frenkel. 2002. Efficacy and toxicity of antiretroviral therapy using 4 or more agents: application of a strategy for antiretroviral management in human immunodeficiency virus-infected children. Arch Pediatr Adolesc Med 156:568-73.
Krogstad P, Lee S, Johnson G, Nachman S, et al and Wiznia AA for the Pediatric AIDS Clinical Trials Group Study Team. 2002. Combination nucleoside analogue(s) reverse transcriptase inhibitors plus nevirapine, nelfinavir or ritonavir in stable antiretroviral therapy-experienced HIV-infected children. Week 48 analysis of Pediatric AIDS Clinical Trials Group 377. (Melvin A.J.) Clinical Infectious Diseases 34:991-1001.
Frenkel, L. M., Y. Wang, G. H. Learn, J. L. McKernan, G. M. Ellis, K. M. Mohan, S. E. Holte, S. M. De Vange, D. M. Pawluk, A. J. Melvin, P. F. Lewis, L. M. Heath, I. A. Beck, M. Mahalanabis, W. E. Naugler, N. H. Tobin, and J. I. Mullins. 2003. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. J Virol 77:5721-30.
Melvin, A. J., and K. M. Mohan. 2003. Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. Pediatrics 111:e641-4.
Flynn PM, Rudy BJ, Douglas SD, Lathey J, Spector SA, Martinez J, Silio M, Belzer M, McNamara J, Hodge J, Hughes MD, Lindsey JC. (Melvin, A.J.) 2004. Virologic and immunologic outcome after 24 weeks in HIV-1 infected adolescents receiving highly active antiretroviral therapy. Journal of Infectious Diseases 190: 271-279.
Melvin, A. J., J. Alarcon, C. Velasquez, C. Rodriguez, J. Piscoya, A. Giraldo, P. Dinh, and L. M. Frenkel. 2004. Rapid HIV-1 Testing of Women Presenting in Late Pregnancy with Unknown HIV Status in Lima, Perú. AIDS and Hum Retro Res 20:1046-52.
Tobin NH, Learn GH, Holte SE, Wang Y, Melvin AJ, McKernan JL, Pawluk DM, Mohan KM, Lewis PF, Mullins JI, Frenkel LM. 2005. Evidence that Low-level Viremias During Effective HAART Result from Two Processes: Expression of Archival Virus and Replication of Virus. J Virol. 79:9625-34.
Johnson DC, McKarland EJ, Muresan P, Fenton T, McNamara J, Read JS, Hawkins E, Bouquin PL, Estep SG, Tomaras GD, Vincent CA, Rathore M, Melvin AJ, Gurunathan S, Lambert J. 2005. Safety and Immunogenicity of an HIV-1 Recombinant Canarypox Vaccine in Newborns and Infants of HIV-1 Infected Women. J Infect Dis 1992;2129-33.
Holte SE, Melvin AJ, Mullins JI, Tobin NH, Frenkel LM. 2006. Density-Dependent Decay in HIV-1 Dynamics. J. Acquir. Immun. Defic. Syndr. and Human Retrovirol; 41: 266-276.
Hitti J, Anderson J, McComsey G, Liu T, Melvin A, Smith L, Stek A, Aberg J, Hull A, Alston-Smith B, Watts H, Livington E. Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084. Am J Obstet Gynecol 2007;196;331.e1-331.e7.
Gupta D, Lhewa D, Viswanath R, Jacob SM, Parameshwari S, Radhakrishnan R, Seidel K, Frenkel L, Samuel NM, Melvin AJ. Effectiveness of antenatal group HIV voluntary counseling and testing (VCT) services in rural India. AIDS Education and Prevention. 2007;41: in press.